Loading...
XNASPOCI
Market cap30mUSD
Jan 10, Last price  
4.80USD
1D
-1.22%
1Q
21.50%
Name

Precision Optics Corporation Inc

Chart & Performance

D1W1MN
XNAS:POCI chart
P/E
—
P/S
1.60
EPS
—
Div Yield, %
0.00%
Shrs. gr., 5y
9.65%
Rev. gr., 5y
22.93%
Revenues
19m
-9.22%
1,349,8192,284,6932,477,4692,902,2193,528,5103,094,4372,245,1372,152,3962,519,7433,651,1813,912,0603,916,7023,154,5474,038,0486,804,1699,923,35510,674,90715,678,24821,044,46719,104,350
Net income
-3m
L+1,940.88%
-3,688,361-2,272,473-2,889,829-1,623,354-992,135-660,882-1,052,613960,972-1,787,680-1,160,638-1,178,793-1,034,765-1,006,457-351,390-614,871-1,426,150-102,835-928,416-144,613-2,951,377
CFO
-3m
L+3,208.68%
-3,127,653-2,272,177-3,334,918-696,868-532,65452,283-413,525-1,585,515-1,293,392-886,031-773,793-876,298-667,434100,657-1,031,693-592,49246,550-933,371-81,090-2,683,012
Earnings
Feb 12, 2025

Profile

Precision Optics Corporation, Inc. designs, develops, manufactures, and sells specialized optical and illumination systems and related components primarily in the United States and the European Economic Area. It offers medical instrumentation products, including endoscopes and endocouplers, as well as other custom imaging and illumination products, such as Microprecision lenses and micro medical cameras, and 3D endoscopes for use in minimally invasive surgical procedures by hospitals and physicians. The company also provides components and assemblies for industrial and military use. It markets its products to medical device companies. The company was incorporated in 1982 and is based in Gardner, Massachusetts.
URL
http://www.poci.com/
IPO date
Jan 16, 1992
Employees
76
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑062023‑062022‑062021‑062020‑062019‑062018‑062017‑062016‑062015‑06
Income
Revenues
19,104
-9.22%
21,044
34.23%
15,678
46.87%
Cost of revenue
14,288
14,303
11,417
Unusual Expense (Income)
NOPBT
4,816
6,742
4,262
NOPBT Margin
25.21%
32.04%
27.18%
Operating Taxes
2
2
952
Tax Rate
0.04%
0.03%
0.02%
NOPAT
4,814
6,740
4,261
Net income
(2,951)
1,940.88%
(145)
-84.42%
(928)
802.82%
Dividends
Dividend yield
Proceeds from repurchase of equity
13
2,288
1,500
BB yield
-0.04%
-6.57%
-4.74%
Debt
Debt current
1,716
937
559
Long-term debt
2,196
2,904
3,110
Deferred revenue
Other long-term liabilities
706
Net debt
3,507
916
3,063
Cash flow
Cash from operating activities
(2,683)
(81)
(933)
CAPEX
(272)
(52)
(153)
Cash from investing activities
(294)
(52)
(408)
Cash from financing activities
456
2,454
1,085
FCF
4,003
6,142
3,403
Balance
Cash
405
2,926
606
Long term investments
Excess cash
1,874
Stockholders' equity
(51,130)
(48,178)
(47,925)
Invested Capital
65,071
63,808
60,602
ROIC
7.47%
10.83%
7.64%
ROCE
34.54%
43.13%
33.62%
EV
Common stock shares outstanding
6,068
5,666
5,296
Price
5.90
-4.07%
6.15
3.02%
5.97
18.45%
Market cap
35,803
2.75%
34,846
10.22%
31,615
41.69%
EV
39,310
35,762
34,679
EBITDA
5,028
6,952
4,452
EV/EBITDA
7.82
5.14
7.79
Interest
225
219
156
Interest/NOPBT
4.67%
3.25%
3.65%